Navigation Links
Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million
Date:1/6/2011

;The financial terms of Montaur's funding commitment are substantially similar to those of the private placement of common stock with regards to the per share purchase price, warrant coverage and terms of the warrants issued to each purchaser.

"The completion of this financing is a watershed event for the Company as we believe that we now have sufficient funds to substantially complete the product development, clinical studies and manufacturing of both our Prelude SkinPrep System, our skin permeation platform technology, and our Symphony tCGM System, our needle-free continuous glucose monitoring system," stated Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.  "We are now fully prepared to support the near-term commercialization of Prelude for the topical delivery of 4% lidocaine cream through our partner, Ferndale Pharma Group.  Additionally, over the coming months we are now able to aggressively finalize the Symphony tCGM biosensor and complete the clinical validation necessary for FDA clearance of the product. This funding enhances the Company's competitive position for Symphony in the glucose monitoring market, a $12 billion-plus annual market opportunity. We look forward to testing our commercially-ready Symphony tCGM System in a clinical trial in the near term and ultimately filing for FDA approval."

The securities issued in the financing have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States in the absence of an effective registration statement or an exemption from the registration requirements under the Securities Act.  This notice does not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state.

About Echo TherapeuticsEc
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
4. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
5. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
6. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
7. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
8. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
9. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
10. Silence Therapeutics Provides Year-end Update
11. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
(Date:10/1/2014)... 1, 2014  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for ... expansion of its European operations with the formation of a ... as General Manager, Germany.  Mr. Schaber will join former Kyphon ... Europe , Middle East ...
(Date:10/1/2014)... R.I. , Oct. 1, 2014  CVS Health ... Month for their role in changing the way health ... improve quality in the Company,s retail pharmacies, mail service ... month, we changed our company name to CVS Health ... expertise in driving the innovations needed to shape the ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 4CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3
... Nov. 23 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ) ... U.S. Food and Drug Administration (FDA) on January 20, 2010 ... Application (NDA) for Intermezzo ® (zolpidem tartrate ... by Transcept on October 28, 2009, indicated that the FDA ...
... , ORANGE COUNTY, Calif., Nov. 23 ... a leading developer, manufacturer, and marketer of products that ... that Allan Harris, Beckman Coulter,s vice president of strategy, ... Wednesday, December 2, 2009 at 12:00 p.m. (ET). , ...
Cached Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2
(Date:10/1/2014)... October 01, 2014 First Warning Systems, ... circadian cellular changes throughout the body, announced the company ... better address the company’s breadth of upcoming product releases. ... cancer screening technology. , “Our initial focus will be ... which detects abnormal circadian cellular changes over time,” said ...
(Date:10/1/2014)... 01, 2014 Join the more than 80 ... Treatment Center’s first ever charity golf tournament to benefit Project ... eating disorders who cannot afford treatment. The tournament will be ... Eureka, Mo. , The day-long event starts with 10:30 ... and award dinner will begin at 5 p.m. and will ...
(Date:10/1/2014)... Innovations announces the upcoming airing of Innovations ... October 20, 2014 at 7:30 a.m. EST/PT via Discovery ... the scenes to learn about Break the Cycle’s comprehensive ... practical help and information Break the Cycle provides to ... of abuse, how to navigate the legal system, and ...
(Date:10/1/2014)... 2014 Scientists at the University of ... target immune system proteins has the power to knock ... details of the new study on their website. ... Researchers in the UWA School of Pathology and Laboratory ... mice with mesothelioma with promising results. , “A ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 October is ... awareness and early detection plans while raising money for ... support Breast Cancer Awareness Month in the effort ... wants to promote the importance of having access to ... water may be linked to certain forms of cancer. ...
Breaking Medicine News(10 mins):Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2
... Attorneys from Dallas, Rasansky Law Firm are ... of the mother of a 2-year-old girl who choked to death ... lawsuit includes claims that the day care,s owners quickly sold the ... from showing up on a state licensing database. , According to ...
... WAYNE, Pa., Nov. 5 Qualsec,s (OTC Bulletin ... received an order from DMC Athletics & ... business will offer products of QLSZ,s wholly-owned subsidiary, ... providing dietary support to their various wellness programs. ...
... DUE TO AN EMBARGO BREAK , From their very first days, ... speak, reveals a new study published online on November 5th in ... that infants begin picking up elements of what will be their ... babble or coo. "The dramatic finding of this study is ...
... left demanding jobs report the most improvement, study finds, , ... doing once retired seems to make a good night,s ... French workers who had retired found that the odds of ... 26 percent lower than in the seven years before they ...
... Research Institute calls for further investigations into the use of ... Nov. 5 Two studies published by the Southwest College ... Clinical Pharmacology investigated the use of oral dimercaptosuccinic acid ... lead poisoning, and used off-label in these studies for treating ...
... ... for the ClearCanvas customer base of more than 5,000 radiology software users worldwide. ... Toronto, Ontario (PRWEB) ... premier support provider for ClearCanvas, Inc. open source RIS/PACS products. Oso Healthcare ...
Cached Medicine News:Health News:The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit; State Investigation Finds Evidence of Negligence at Woodbridge Day School 2Health News:Qualsec's Wholly-Owned Subsidiary Receives Order From New Jersey-Based DMC Athletics and Rehabilitation 2Health News:Babies' language learning starts from the womb 2Health News:Without Job Stress, Retirees Sleep Better 2Health News:Chelation Therapy Drug Found Safe and Beneficial for Children With Autism 2Health News:Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS/PACS 2Health News:Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS/PACS 3Health News:Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS/PACS 4
Help restore pelvic muscle function with the Prometheus Pathway CTS 2000 evaluation and training system....
... catheters with secondary sensors placed in the ... test also provides information about acid control ... stomach or proximal esophageal acid exposure and ... Ability to record pH simultaneously in up ...
... the advance of digital imaging technology, ... towards digital formats, allowing for easier ... advance in digital pathology imaging is ... in radiology, and which is continuing ...
... SONOLINE G40 ultrasound system brings,the benefits ... entirely new level of diagnostic performance,and ... that meets your clinical needs. With ... and pulsed-wave Doppler capabilities,the G40 system ...
Medicine Products: